Clinical Study
Comparative Study of the Effects of 1% Atropine on the Anterior Segment
Table 2
Univariate analysis of the associations between ΔTIA and the ocular and general parameters.
| Variables | Univariate analysis | Regression coefficient (95% confidence interval) | R2 | value |
| Age | −0.324 (−1.049 to 0.463) | −0.008 | 0.578 | Sex | −3.256 (−15.717 to 0.085) | 0.017 | 0.164 | ΔAOD500 (mm) | 26.64 (14.871 to 38.146) | 0.251 | <0.05 | ΔACD (mm) | 3.007 (−13.465 to 19.478) | −0.015 | 0.716 | ΔLV (mm) | 8.448 (−2.589 to 19.741) | 0.009 | 0.226 | ΔACW (mm) | 0.766 (−2.881 to 3.766) | −0.014 | 0.665 | ΔIT750 (mm) | 1.743 (−17.353 to 21.07) | −0.017 | 0.871 | ΔIT1500 (mm) | −9.287 (−35.575 to 18.34) | −0.008 | 0.467 | ΔIA (mm67) | −2.34 (−8.122 to 5.676) | −0.012 | 0.557 | ΔCBT0 (mm) | 5.693 (−7.496 to 18.84) | −0.007 | 0.436 | ΔCMTmax (mm) | 8.252 (−19.678 to 37.582) | 0.012 | 0.574 | ΔTCA (CA) | 0.189 (0.057 to 0.344) | 0.123 | 0.004 | ΔTCPD (mm) | −4.274 (−14.436 to 6.66) | −0.009 | 0.484 | ΔICPD (mm) | −3.513 (−17.697 to 12.185) | −0.014 | 0.641 | ΔSIA (IA) | 0.4 (0.204 to 0.591) | 0.185 | <0.05 | ΔSCPA (CP) | 0.071 (−0.264 to 0.331) | −0.012 | 0.579 | AOD500 (mm) | −2.007 (−13.807 to 11.251) | −0.016 | 0.735 | ACD (mm) | −6.162 (−16.044 to 3.72) | 0.01 | 0.217 | LV (mm) | 5.148 (−8.016 to 18.312) | −0.007 | 0.437 | ACW (mm) | 1.018 (−2.317 to 4.353) | −0.011 | 0.543 | IT750 (mm) | 10.254 (−13.994 to 33.17) | −0.003 | 0.371 | IT1500 (mm) | −0.945 (−36.492 to 35.326) | −0.018 | 0.954 | IA (mm54) | −0.745 (−9.2 to 7.709) | −0.017 | 0.86 | CBT0 (mm) | 8.709 (−13.341 to 32.765) | −0.005 | 0.399 | CMTmax (mm) | 3.865 (−23.512 to 30.92) | −0.016 | 0.785 | TCA (CA) | 0.114 (−0.046 to 0.268) | 0.013 | 0.193 | TCPD (mm) | −11.043 (−24.1 to 2.248) | 0.022 | 0.137 | ICPD (mm) | −6.593 (−21.547 to 8.072) | −0.008 | 0.469 | SIA (IA) | −0.016 (−0.344 to 0.312) | −0.018 | 0.922 | SCPA (CP) | −0.007 (−0.299 to 0.286) | −0.018 | 0.964 | TIA (IA) | 0.375 (0.128 to 0.631) | 0.96 | 0.01 |
|
|